Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorr

Showing results (931-940 of 1,229) with videos related to

Pageof 123
Sort By:
Biodiversity Data Journal|December 5, 2017
Applications of deep convolutional neural networks to digitized natural history collectionsEric Schuettpelz, Paul B Frandsen, Rebecca B Dikow, et al.
Molecular Cancer Therapeutics|December 7, 2002
Molecular and cellular characterization of imexon-resistant RPMI8226/I myeloma cellsKaterina Dvorakova, Claire M Payne, Margaret E Tome, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 24, 2001
Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon EH H Chow, Y Cai, D S Alberts, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 23, 2011
Sources of alveolar soluble TNF receptors during acute lung injury of different etiologiesAnthony D Dorr, Michael R Wilson, Kenji Wakabayashi, et al.
Antimicrobial Agents and Chemotherapy|August 5, 2025
Pharmacokinetics and safety of single and repeat doses of ceftibuten in healthy participants: a phase 1 dose escalation studyMary Beth Dorr, Carlos Fernando de Oliveira, Jeroen van de Wetering, et al.
Medical Care|April 6, 2021
Racial and Ethnic Differences in Multimorbidity Changes Over TimeAna R Quiñones, Jason T Newsom, Miriam R Elman, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1991
Transrectal ultrasound, digital rectal examination, and prostate-specific antigen: preliminary results of an early detection program for prostate cancerF Lee, T A McHugh, M H Solomon, et al.
Environmental Research|November 27, 2009
Housing and allergens: a pooled analysis of nine US studiesJonathan Wilson, Sherry L Dixon, Patrick Breysse, et al.
Phytotherapy Research : PTR|August 5, 2000
A phase I trial of andrographolide in HIV positive patients and normal volunteersC Calabrese, S H Berman, J G Babish, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancerSridhar Mani, Charles M Rudin, Katie Kunkel, et al.
Pageof 123

Showing results (931-940 of 1,229) with videos related to

Sort By:
Pageof 123
Biodiversity Data Journal|December 5, 2017
Applications of deep convolutional neural networks to digitized natural history collectionsEric Schuettpelz, Paul B Frandsen, Rebecca B Dikow, et al.
Molecular Cancer Therapeutics|December 7, 2002
Molecular and cellular characterization of imexon-resistant RPMI8226/I myeloma cellsKaterina Dvorakova, Claire M Payne, Margaret E Tome, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 24, 2001
Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon EH H Chow, Y Cai, D S Alberts, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 23, 2011
Sources of alveolar soluble TNF receptors during acute lung injury of different etiologiesAnthony D Dorr, Michael R Wilson, Kenji Wakabayashi, et al.
Antimicrobial Agents and Chemotherapy|August 5, 2025
Pharmacokinetics and safety of single and repeat doses of ceftibuten in healthy participants: a phase 1 dose escalation studyMary Beth Dorr, Carlos Fernando de Oliveira, Jeroen van de Wetering, et al.
Medical Care|April 6, 2021
Racial and Ethnic Differences in Multimorbidity Changes Over TimeAna R Quiñones, Jason T Newsom, Miriam R Elman, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1991
Transrectal ultrasound, digital rectal examination, and prostate-specific antigen: preliminary results of an early detection program for prostate cancerF Lee, T A McHugh, M H Solomon, et al.
Environmental Research|November 27, 2009
Housing and allergens: a pooled analysis of nine US studiesJonathan Wilson, Sherry L Dixon, Patrick Breysse, et al.
Phytotherapy Research : PTR|August 5, 2000
A phase I trial of andrographolide in HIV positive patients and normal volunteersC Calabrese, S H Berman, J G Babish, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancerSridhar Mani, Charles M Rudin, Katie Kunkel, et al.
Pageof 123